Top 5 China Stocks To Own Right Now


The last time we saw today's setup, one group of stocks more than doubled in four years and left U.S. stocks in the dust…   It has nothing to do with China. And it might surprise you…   European stocks are now dirt-cheap compared with their U.S. counterparts.   Based on history, that means we could see an incredible scenario… European stocks could significantly outperform the overall U.S. market during the next four years.   Don't get me wrong… I am still bullish on U.S. stocks over the next 12 to 18 months. I think they will absolutely soar, thanks to the last explosive phase in this bull market, which I've called the "Melt Up." But Europe could do even better.   Let me share the details…   U.S. stocks crushed European stocks in 2016… The S&P 500 Index soared 12%, while the STOXX Europe 600 Index actually fell 1%.

Top 5 China Stocks To Own Right Now: Top Image Systems Ltd.(TISA)


Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Top Image Systems (TISA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    Before we get to our latest pick, here are last week’s top-performing penny stocks:

    Penny Stock Sector Current Share Price Last Week’s Gain
    Melinta Therapeutics Inc. (NASDAQ: MLNT) Healthcare $1.74 104.01%
    Pernix Therapeutics Holdings Inc. (NASDAQ: PTX) Healthcare $0.83 84.40%
    Top Image Systems Ltd. (NASDAQ: TISA) Healthcare $0.82 59.85%
    Jason Industries Inc. (NASDAQ: JASN) Healthcare $2.21 58.99%
    Maxwell Technologies Inc. (NASDAQ: MXWL) Financial $4.66 51.79%
    Marathon Patent Group Inc. (NASDAQ: MARA) Healthcare $0.52 51.47%
    Forward Pharma A/S (NASDAQ: FWP) Basic Materials $1.53 43.57%
    Dixie Group Inc. (NASDAQ: DXYN) Healthcare $1.40 42.86%
    Trevena Inc. (NASDAQ: TRVN) Services $1.41 39.60%
    Alliance MMA Inc. (NASDAQ: AMMA) Healthcare $4.95 36.18%


    Don’t Miss Out: The Treasury is sitting on an $11.1 billion cash pile, and a loophole entitles Americans to a sizable portion. Some are collecting $1,795, $3,000, or $5,000 every month thanks to this powerful investment…

Top 5 China Stocks To Own Right Now: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was a relatively quiet day on Wall Street, and action in different parts of the market showed mixed signals for investors. On one hand, small-cap stocks moved higher, with key benchmarks in that area hitting record highs. Yet the better-known large-cap stock indexes like the S&P 500 gave up early gains. Looking more closely at individual stocks, some companies suffered from bad news that sent their shares falling. J.C. Penney (NYSE:JCP), NetEase (NASDAQ:NTES), and Jounce Therapeutics (NASDAQ:JNCE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    NetEase Inc (NYSE: NTES) is the largest online services provider in China with revenue from its e-commerce platform and online gaming. Sales on its e-commerce platform surged 157% last year to support slower growth in gaming which accounts for about 75% of total revenue. The company is also starting to monetize its gaming segment with movies and mini-series based on the characters in the games.

  • [By Harsh Chauhan]

    Over the years, NetEase (NASDAQ:NTES) has made the most of the opportunities presented by China’s mobile and online gaming market, and has also diversified into fast-growing verticals like ecommerce to supercharge its prospects. Not surprisingly, NetEase investors have been a happy lot, as their investment in the Chinese internet specialist has experienced five straight years of double-digit percentage gains.

  • [By Steve Symington]

    Shares of NetEase Inc. (NASDAQ:NTES) climbed 15.4% in September, according to data from S&P Global Market Intelligence, rebounding from their 52-week low with the help of two notable analyst upgrades.

Top 5 China Stocks To Own Right Now: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get ReneSola alerts:


    ReneSola Sells North Carolina Solar Project To Greenbacker (solarindustrymag.com) ReneSola (SOL) Rating Increased to Neutral at Roth Capital (americanbankingnews.com) ReneSola (SOL) Q1 Earnings in Line, Revenues Top Estimates (zacks.com) ReneSola’s (SOL) CEO Xianshou Li on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) ReneSola (SOL) Releases Earnings Results (americanbankingnews.com)

    Shares of ReneSola traded up $0.08, hitting $2.76, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 124,969 shares, compared to its average volume of 108,565. The firm has a market capitalization of $102.11 million, a PE ratio of 21.23 and a beta of 2.05. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.36. ReneSola has a 12 month low of $2.12 and a 12 month high of $3.79.

  • [By Max Byerly]

    Sola Token (CURRENCY:SOL) traded up 26.7% against the US dollar during the 24 hour period ending at 22:00 PM E.T. on September 28th. One Sola Token token can currently be bought for $0.0085 or 0.00000131 BTC on popular exchanges including Tidex and OpenLedger DEX. Sola Token has a market capitalization of $0.00 and approximately $3,239.00 worth of Sola Token was traded on exchanges in the last 24 hours. During the last week, Sola Token has traded flat against the US dollar.

  • [By Max Byerly]

    Sola Token (CURRENCY:SOL) traded 17.9% lower against the dollar during the 1-day period ending at 16:00 PM E.T. on October 11th. One Sola Token token can now be bought for about $0.0054 or 0.00000087 BTC on cryptocurrency exchanges including Tidex and OpenLedger DEX. Sola Token has a total market cap of $153,306.00 and $1,856.00 worth of Sola Token was traded on exchanges in the last 24 hours. In the last seven days, Sola Token has traded down 12.2% against the dollar.

Top 5 China Stocks To Own Right Now: ATA Inc.(ATAI)


Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 5 China Stocks To Own Right Now: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of CDTi Advanced Materials Inc (NASDAQ:CDTI) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $0.33 and last traded at $0.36, with a volume of 500 shares trading hands. The stock had previously closed at $0.36.

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Molecular Templates alerts:

    Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)

    MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.